Aimei Health Technology Co., Ltd filed a Form 8-K on November 19, 2026, reporting shareholder approval at an Extraordinary General Meeting held November 10, 2026, to extend the deadline for consummating an initial business combination from 36 months to 48 months from the date of its IPO.

Key Highlights

  • Extended deadline: The business combination deadline was extended from December 6, 2026 to December 6, 2027, adding 12 months to the original 36-month window.
  • Trust deposit requirement: Monthly extension deposits into the trust account are the lesser of $80,000 for all outstanding Public Shares or $0.033 per outstanding Public Share.
  • Record date shares: On the October 2, 2026 record date, the company had 3,166,332 ordinary shares issued and outstanding.
  • Article Amendment vote: Proposal 1 received 2,757,268 votes for, 5,377 against, and 16 abstentions, with 79,881 broker non-votes.
  • Auditor appointment: Shareholders approved MaloneBailey, LLP as the independent registered public accounting firm for the year ending December 31, 2026, with 2,840,119 votes for, 1,961 against, and 462 abstentions.
  • Articles of association amended: Article 35.2 was amended and restated, with the amendment taking effect upon shareholder approval on November 10, 2026 under Cayman Islands law.

Aimei Health Shareholders Vote to Push Business Combination Window to 48 Months

According to the filing, Aimei Health Technology Co., Ltd (NASDAQ:AFJK) held an Extraordinary General Meeting virtually on November 10, 2026, with the board having set October 2, 2026 as the record date. Shareholders voted on four proposals covering an amendment to the company's articles of association, an amendment to its Investment Management Trust Agreement, the appointment of an independent auditor, and an adjournment provision. All four proposals were approved.

The company disclosed that it entered into a third amendment to its Investment Management Trust Agreement, dated December 1, 2023, with Continental Stock Transfer and Trust Company as trustee. The Trust Agreement Amendment extends the period within which the company may consummate its initial business combination from up to 36 months from the IPO date (December 6, 2026) to up to 48 months from the IPO date (December 6, 2027). The filing states that the deposit required for each monthly extension remains the lesser of $80,000 for all outstanding Public Shares and $0.033 for each outstanding Public Share.

In parallel, the filing reports that Article 35.2 of the company's Amended and Restated Articles of Association was amended to reflect the same extended deadline. Under Cayman Islands law, the amendment took effect upon approval at the Extraordinary General Meeting on November 10, 2026, and the company indicated it will forward a copy of the special resolution to the Cayman Islands Registrar of Companies. For the Adjournment Proposal, 2,834,906 shares voted for, 7,174 against, and 462 abstained, with no broker non-votes recorded.

What Was Disclosed

Aimei Health Technology Co., Ltd reported shareholder approval of a 12-month extension to its business combination deadline, amendments to its trust agreement and articles of association, and the appointment of MaloneBailey, LLP as independent auditor for fiscal year 2026.